Archemix and SomaLogic Align to Advance the Use of Aptamers
Alliance Promotes Development of Novel Diagnostics and Therapeutics
26-Sep-2003 -
Two of the exclusive licensees of aptamer technology, Archemix Corp., a privately held biopharmaceutical company, and SomaLogic, Inc., a privately held proteomics company, announced today an alliance that will facilitate the broad use of aptamers as powerful tools in the diagnosis and treatment ...
acids
aptamer therapeutics
aptamers
+10